U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S.
Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will now rein in Medicaid drug prices to match what they charged in other developed countries.
As part of the deal, new drugs made by those companies will also be charged at the so-called “most-favored-nation” pricing across the country on any newly launched medications for all, including commercial and cash pay markets as well as Medicare and Medicaid.
Drug prices for patients in the U.S. can depend on a number of factors, including the competition a treatment faces and insurance coverage. Most people have coverage through work, the individual insurance market or government programs like Medicaid and Medicare, which shield them from much of the cost.
Patients in Medicaid, the state and federally funded program for people with low incomes, already pay a nominal co-payment of a few dollars to fill their prescriptions, but lower prices could help state budgets that fund the programs.
Lower drug prices also will help patients who have no insurance coverage and little leverage to negotiate better deals on what they pay. But even steep discounts of 50% found through the administration’s website could still leave patients paying hundreds of dollars a month for some prescriptions.
William Padula, a pharmaceutical and health economics professor at USC, said Medicaid already has the most favorable drug rates which in some cases will be close to what the “most-favored-nation” price is so it remains to be seen what other impacts it could have, such as more research and development.
“It can’t be bad. I don’t see much downside but it’s hard to judge what the upside is,” Padula said.
And while it is significant that Trump was able to get big drugmakers to the table to negotiate lower prices, it will take years to gage how effective this initiative is in terms of more people obtaining more of the medicines they need.
“It’s good for their stock and it’s good for their future” research and development, Padula said of the pharmaceutical companies. “It’s clearly influential but will all this add up to a major effect? Nothing really matters here unless our health gets better as a country.”
Trump administration officials said the drugmakers will also sell pharmacy-ready medicines on the TrumpRx platform, which is set to launch in January and will allow people to buy drugs directly from manufacturers.
Companies such as Merck, GSK and Bristol Myers Squibb also agreed to donate significant supplies of active pharmaceutical ingredients to a national reserve and to formulate and distribute them into medications such as antibiotics, rescue inhalers and blood thinners as needed in an emergency.
The New Jersey-based Bristol Myers Squibb further announced that it will be giving for free to the Medicaid program its signature blood thinner prescribed to reduce the risk of blood clots and stroke. Known as Eliquis, it is the company’s top prescribed drug as well as being one of Medicaid’s most widely-used medicines.
Padula said the donations — which encompass some of the world’s most critical medicines — are a significant step toward health equity and an acknowledgement that the drugmakers can afford to seek profits elsewhere in their operations. Eliquis already has been one of the most profitable drugs ever made.
“It’s a thoughtful health equity move that they can afford given that it’s been such a blockbuster,” Padula said of the Eliquis donation.
Other major drugmakers including Pfizer, AstraZeneca, EMD Serono, Novo Nordisk and Eli Lilly struck similar deals with the Trump administration earlier this year.
Though individual terms were not disclosed, the administration has now negotiated lower drug prices with 14 companies since Trump publicly sent letters to executives at 17 pharmaceutical companies about the issue, noting that U.S. prices for brand-name drugs can be up to three times higher than averages elsewhere.
Trump said he effectively threatened the pharmaceutical companies with 10% tariffs to get them to “do the right thing.”
President Donald Trump speaks during an event on prescription drug prices in the Roosevelt Room of the White House, Friday, Dec. 19, 2025, in Washington. (AP Photo/Evan Vucci)
He's done it again. Nikola Jokic will average a triple-double this season.
The Denver star had 15 points, 17 rebounds and 12 assists on Wednesday, helping the Nuggets beat the Utah Jazz 130-117.
Jokic now has exactly 660 assists this season. Denver has five games left and if Jokic plays in them all, he would average 10.0 assists — even if he doesn't get another one all season. He's already ensured that he would average double-figures in points and rebounds as well.
Russell Westbrook had four seasons in which he averaged a triple-double. Jokic has now done it twice — he did it last season as well — and Oscar Robertson did it once.
Westbrook, Jokic and Robertson are the only players who have pulled it off.
The Lakers and Denver both clinched playoff spots on Tuesday night. They join Detroit, Boston, New York, Oklahoma City and San Antonio on the list of teams with playoff spots secured.
The postseason (not playoff) teams are set: Milwaukee, Chicago, Washington, Brooklyn and Indiana have all been eliminated from the Eastern Conference race while Memphis, New Orleans, Dallas, Utah and Sacramento are out of the Western Conference race.
Portland, Golden State and the Los Angeles Clippers are locked into the play-in tournament.
— 76ers 153, Wizards 131: Paul George scores 39, Philly shoots 62% and moves into No. 6 in East.
— Hawks 130, Magic 101: Atlanta improves to 17-2 in last 19 games, while Orlando falls to No. 9 in East.
— Celtics 147, Heat 129: Boston scores 53 in 1st quarter, Jaylen Brown has 43, Jayson Tatum triple-double.
— Knicks 130, Grizzlies 119: New York responds to Josh Hart’s pleas for better play, gets easy win.
— Kings 123, Raptors 115: Bad loss for Toronto, which gets outrebounded 48-32 and falls to No. 7 in the East.
— Pacers 145, Bulls 126: Did anyone in the NBA play any defense on Wednesday night?
— Rockets 119, Bucks 113: Spirited effort from seriously short-handed Bucks, but Houston’s starters outscore Milwaukee’s 101-80.
— Nuggets 130, Jazz 117: Jamal Murray had 37 for Denver, Nikola Jokic added another triple-double and Utah used only eight players in the game.
— Spurs 127, Warriors 113: A 41-point, 18-rebound game for MVP hopeful Victor Wembanyama, and San Antonio improves to 26-2 since Feb. 1.
— Phoenix at Charlotte: Devin Booker had 30 points, 10 assists in Phoenix win over Charlotte last month.
— Minnesota at Detroit: Detroit just keeps rolling, even with Cade Cunningham sidelined.
— L.A. Lakers at Oklahoma City: Matchup of MVP contenders in Lakers' Luka Doncic, Thunder’s Shai Gilgeous-Alexander.
— Cleveland at Golden State: Warriors know they’re in West play-in, while Cavs are on brink of clinching East top-4 seed.
— New Orleans at Portland: Pelicans building toward next season, Blazers could host a play-in game.
— San Antonio at L.A. Clippers: Spurs still chasing that No. 1 seed, Clippers know they’ll be in play-in.
— Indiana at Charlotte: A winning record this season is going to get Hornets’ coach Charles Lee some award votes.
— Minnesota at Philadelphia: Massive implications seeding-wise for both teams.
— Atlanta at Brooklyn: Hawks closing in on Southeast Division title, possibly No. 5 seed.
— Chicago at New York: Knicks nearing the 50-win mark yet again.
— Utah at Houston: The Rockets know they can’t afford a slipup in this spot.
— Toronto at Memphis: Raptors need a few wins down the stretch to avoid play-in.
— Boston at Milwaukee: Bucks coach Doc Rivers faces his former team, a day before expected Hall of Fame formal announcement.
— Orlando at Dallas: Magic coach Jamahl Mosley enjoyed a lot of nights when he was on the Mavs’ staff. He desperately needs one of those good nights here.
— New Orleans at Sacramento: A pair of teams building for the future.
Thursday's games on Prime: Minnesota-Detroit and L.A. Lakers-Oklahoma City.
Friday on NBA TV: Chicago-New York.
Oklahoma City (+135) is favored to win the NBA title, according to BetMGM Sportsbook, followed by Boston (+600), San Antonio (+600), Cleveland (+1000), Denver (+1100) and New York (+1600). Detroit, on its way to the No. 1 seed in the East, is +2500.
— April 10: All 30 teams play their 81st games of the season.
— April 12: All 30 teams play their regular season finales.
— April 14, 15 and 17: NBA play-in tournament dates.
— April 18 and 19: NBA playoff series openers.
— May 2, 3 or 4: Conference semifinals begin.
— May 10: NBA draft lottery.
— May 10-17: NBA draft combine.
— May 17 or 19: Eastern Conference finals begin on ESPN and ABC.
— May 18 or 20: Western Conference finals begin on NBC and Peacock.
— June 3: Game 1, NBA Finals on ABC. (Other finals dates: June 5, June 8, June 10, June 13, June 16 and June 19).
Sacramento's DeMar DeRozan passed Dominique Wilkins (26,668) for 17th on the NBA's all-time scoring list on Wednesday in Toronto. He's now 22 points behind No. 16 Oscar Robertson (26,710).
No team in NBA history had made 24 3-pointers and lost by more than 11 points. (Most hadn't lost at all; the record for teams with 24 or more 3s was 117-9). That is, until Wednesday, when Miami made 24 3s ... and lost by 18 to Boston.
AP NBA: https://apnews.com/nba
Miami Heat guard Pelle Larsson, left, is fouled by Philadelphia 76ers center Adem Bona, right, during the second half of an NBA basketball game, Monday, March 30, 2026, in Miami. (AP Photo/Lynne Sladky)
Boston Celtics guard Jaylen Brown (7) dunks against the Atlanta Hawks in the second half of an NBA basketball game, Monday, March 30, 2026, in Atlanta. (AP Photo/Mike Stewart)
Toronto Raptors centre Jakob Poeltl (front) is fouled by Orlando Magic centre Goga Bitadze (back left) as Magic forward Paolo Banchero (right) looks on during first half NBA action in Toronto on Sunday, March 29, 2026. (Frank Gunn/The Canadian Press via AP)
Boston Celtics forward Jayson Tatum, right, drives against Charlotte Hornets guard Kon Knueppel during the second half of an NBA basketball game in Charlotte, N.C., Sunday, March 29, 2026. (AP Photo/Nell Redmond)
